Infosys Launches Topaz Fabric for AI-Powered Enterprise Transformation
Infosys has launched Infosys Topaz Fabric, a composable stack of AI agents, services, and models designed to accelerate value from enterprise…
Wockhardt Board Approves Q2 Results and Appoints New Independent Director
Wockhardt’s Board of Directors has approved the unaudited financial results for the quarter and half-year ended September 30, 2025.…
Petronet LNG Analyst/Investor Meetings Scheduled for November 2025
Petronet LNG has announced its schedule of meetings with analysts and institutional investors for November 2025. The schedule includes the UBS…
Alkem Laboratories Alkem Foundation & IIT Bombay Partner for Research Center
Alkem Foundation and IIT Bombay are collaborating to establish a research center for immuno-therapeutics and regenerative medicines. The Alkem…
Ambuja Cements Confirmation of No Deviation in Preferential Issue Proceeds
Ambuja Cements confirms no deviations or variations in the use of proceeds from its preferential issue of equity shares for the quarter ended…
Ambuja Cements FY’26 Target Capacity Increased to 155 MTPA
Ambuja Cements has announced an increase in its FY’28 target capacity to 155 MTPA, up from the previous 140 MTPA. This will be achieved…
Ambuja Cements Q2 FY’26 Revenue Soars, Capacity Expansion Underway
Ambuja Cements reported a strong Q2 FY’26 with revenue at ₹9,174 Cr, up 21% YoY. EBITDA reached ₹1,060/PMT. The company is increasing…
Ajanta Pharma Record Date Set for Interim Dividend
Ajanta Pharma has announced November 10, 2025, as the record date for determining shareholders eligible to receive the company’s first…
Ajanta Pharma PAT Up 20% in Q2 FY26, Interim Dividend Declared
Ajanta Pharma announced a 20% increase in Profit After Tax (PAT) for Q2 FY26. The company’s revenue from operations rose by 14% to…
Ambuja Cements Achieves Robust Q2 FY26 Performance, PAT Up 364%
Ambuja Cements reported a strong Q2 FY26 performance, with PAT at Rs. 2,302 Cr, up 364% YoY. The company achieved its highest ever quarterly…